PLATINEA: Platform for Innovation of Existing Antibiotics
| Reference number | |
| Coordinator | Uppsala universitet - Institutionen för elektroteknik |
| Funding from Vinnova | SEK 9 732 403 |
| Project duration | December 2018 - April 2021 |
| Status | Completed |
| Venture | Challenge-driven innovation - Phase 2 Collaboration |
Purpose and goal
PLATINEA’s vision is to “Maintain the value of existing antibiotics for future generations”, which can be achieved by giving “the right antibiotic to the right patient, at the right moment and with the right dosage”. In order to reach these goals PLATINEA has created a unique collaboration platform that enables healthcare, industry, academia and public authorities to work together to identify new solutions against shortages and to create and implement new evidence to improve the use of antibiotics.
Expected results and effects
PLATINEA’s results include a national inventory of knowledge gaps for optimization studies and of important antibiotics with risk of shortages. PLATINEA also identified 60 causes and 10 priority measures against antibiotics shortages. Evidence for optimizing antibiotic use has been created through studies on effect and resistance development, as well as evaluations of models and software for individual dosage. PLATINEA has also contributed to implementing ward rounds, increased collaboration between pediatric clinics and 24/7 diagnostic services.
Planned approach and implementation
PLATINEA is a system-wide innovation for the antibiotic field as it created a multi-sectorial platform where the four sectors healthcare, industry, academic and public authorities can collaborate and have an open dialogue, which was previously missing. PLATINEA also applies an innovative coordination model based on four work-packages (WPs) whereby a regular inventory of national needs (WP1) steers both the measures to improve accessibility (WP4) and the choice of optimization studies (WP2), whose results will then be implemented in healthcare (WP3).